UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness. The findings,…
Continue Reading
News Source: medicalxpress.com
Leave a Reply